Agilent Technologies Inc. shares are up during Monday’s premarket session as the company announces the acquisition of Biocare Medical for around $950 million. Biocare Medical has been a prominent ...

Cambridge researchers map the convergence of biomarkers, digital phenotyping, and AI toward biologically grounded ...

Mechelen, Belgium, 10 March 2026 – Today, Biocartis announced that its Idylla™ CDx MSI Test has received Class C companion diagnostic ( CDx) certification under the EU’s IVDR1 as a CDx for colorectal ...

Biocare has been under the stewardship of VC firms Excellere Partners and GHO Capital since 2021, achieving revenue of $90m in 2025.

Condom-maker Cupid's shares surged 5% on Tuesday, extending this week's gains to 19% following its 4:1 bonus issue. The bonus shares are expected to be allotted today, making the stock more accessible ...

Cupid Share Price jumps nearly 15% to ₹92 today as investors rush in on bonus issue record date; company to allot shares in 4:1 ratio to eligible shareholders.

Agilent Technologies Inc. today announced it has entered into a definitive agreement to acquire Biocare Medical, a global leader in clinical pathology, from an investor group led by Excellere Partners ...

This 297 patient study provides additional evidence in support of TruScreen + hr HPV co testing strategies, demonstrating performance advantages over TCT + hr HPV while utilising TruScreen’s real time ...

HOLX's Diagnostics unit faces COVID-19 test declines, but Panther Fusion expansion, new assays and AI-driven Genius system support long-term growth potential.

Solabia announces the acquisition of the Botanical Actives and In-Vitro Diagnostics (“IVD”) activity of SEQENS, which ...